Sunrise Medical is a world leader in the development, design, manufacture and distribution of manual wheelchairs, power wheelchairs, motorised scooters and both standard and customised seating and positioning systems.

Sunrise Medical is a leading company in the worldwide development, design, manufacture and distribution of mobility products. Their key products are sold through a network of homecare medical product providers or distributors in over 130 countries.

The company employs over 2,000 associates worldwide and manufactures products in their own facilities in the United States, Mexico, Germany, United Kingdom, Spain, Netherlands, Poland and China.

Nordic Capital Fund VII acquired Sunrise Medical in July 2015. The aim is to accelerate Sunrise’s market leading position in premium manual wheelchairs and continue to grow in powered wheelchairs.

In April 2018, Nordic Capital’s 2008 vintage fund, Fund VII completed the transfer of its remaining nine unlisted portfolio companies including Acino, to a continuation vehicle, Nordic Capital CV1 or "CV1". Fund VII’s original term expired in December 2017 and by this transaction, Nordic Capital took the opportunity to maximise the value creation potential of these nine companies, providing them with active support and fresh capital over an additional five-year holding period under continued Nordic Capital management.

Key Information

Revenues Icon

Revenues 2017*

EUR 470 million

Employees Icon

Employees

2230

Ownership Icon

Ownership

Nordic Capital Fund VII, Nordic Capital CV1

Head Office Icon

Head office

Malsch, Germany

Investment Icon

Investment date

2015, 2018

* Reported